trial · primary record
Zotiraciclib
Brain Tumor
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 96 |
| Primary completion | 2032-08-02 |
| Primary endpoint | To determine 12 months PFS in participants w/ recurrent glioma, IDH1/2-mutant, WHO grade 3 treated w/ zotiraciclib in comparison w/ the established brain tumor database matched for tumor molecular characteristics and clinical prognostic factors |
| Registry ID | NCT05588141 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:46.374Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05588141
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.